title: The quintessence of immunogenicity reporting for biotherapeutics.
authors: Janssen Research &Development, LLC (Johnson &Johnson), Spring House, Pennsylvania, USA.
authors: Gopi
authors: G
authors: Shankar
authors: Pfizer Worldwide Research &Development, Cambridge, Massachusetts, USA.
authors: Steven
authors: S
authors: Arkin
authors: AbbVie, Inc., Chicago, Illinois, USA.
authors: Viswanath
authors: V
authors: Devanarayan
authors: IPM Biotech GmbH, Hamburg, Germany.
authors: Arno
authors: A
authors: Kromminga
authors: Genentech, South San Francisco, California, USA.
authors: Valerie
authors: V
authors: Quarmby
authors: Sanofi, Framingham, Massachusetts, USA.
authors: Susan
authors: S
authors: Richards
authors: Biogen Idec, Cambridge, Massachusetts, USA.
authors: Meena
authors: M
authors: Subramanyam
authors: Amgen Inc., Thousand Oaks, California, USA.
authors: Steven
authors: S
authors: Swanson
mesh_terms: D001688:Biological Products / Q000009:adverse effects* / Q000276:immunology*; D001702:Biopharmaceutics / Q000379:methods*; D030881:Disclosure; D004348:Drug Labeling / Q000379:methods; D006801:Humans; D007154:Immune System Diseases / Q000139:chemically induced* / Q000276:immunology*
chemical_list: D001688:Biological Products